| Patients (n = 72) | Carers (n = 17)c | |||
---|---|---|---|---|---|
Stage I (n = 18) | Stage II (n = 10)a | Stage III (n = 16)b | Stage IV (n = 28) | ||
Melanoma diagnosis: | |||||
  < 1 month ago | – | – | – | – | – |
 1–3 months ago | 6% | – | – | – | – |
 3–6 months ago | 17% | – | 7% | 4% | – |
 6–12 months ago | 28% | 10% | 13% | 11% | 6% |
 1–2 years ago | 6% | 20% | 7% | 25% | 29% |
 2–5 years ago | 22% | 50% | 40% | 43% | 24% |
  > 5 years ago | 22% | 20% | 33% | 18% | 41% |
Type of Melanoma:d | |||||
 Cutaneous melanoma | 44% | 70% | 57% | 64% | 62% |
 Ocular/ Uveal/Choroidal melanoma | 50% | 10% | 7% | 18% | 12% |
 Acral melanoma | – | – | – | – | 6% |
 Mucosal melanoma | – | – | – | – | – |
 I don’t know | 6% | 20% | 36% | 18% | 19% |
Melanoma mutations: | |||||
 BRAF mutant | 11% | 20% | 27% | 46% | 53% |
 BRAF wild-type | – | – | – | 18% | 18% |
 NRAS mutant | – | – | – | 7% | – |
 c-kit mutant | – | – | – | 4% | 6% |
 GNAQ/GNA11 | – | – | 7% | 4% | – |
 I don’t know | 78% | 60% | 67% | 11% | 18% |
 None | 6% | 10% | – | 4% | 6% |
 Othere | 6% | 10% | – | 7% | – |
Treatments receivedf | |||||
 Surgery | 89% | 90% | 94% | 89% | 100% |
 Radiotherapy | 39% | 20% | 13% | 39% | 26% |
 Chemotherapy | – | 11% | 6% | 25% | 21% |
 Immune Therapies | – | – | 25% | 81% | 56% |
 Targeted Therapies | – | – | 6% | 27% | 50% |